51. Pulmonary Alveolar Proteinosis in Association with Secondary Hemophagocytic Lymphohistiocytosis
- Author
-
Jenny Lin, Aliva De, Emily Wasserman, Jacqueline Weingarten, Giles J. Peek, Rochelle R. Maxwell, Michael Miksa, Kelly Adams, and Lisa Figueiredo
- Subjects
Secondary Hemophagocytic Lymphohistiocytosis ,Pathology ,medicine.medical_specialty ,medicine.medical_treatment ,030204 cardiovascular system & hematology ,Pulmonary Alveolar Proteinosis ,Risk Assessment ,Severity of Illness Index ,Lymphohistiocytosis, Hemophagocytic ,03 medical and health sciences ,0302 clinical medicine ,Rare Diseases ,Tracheostomy ,Langerhans cell histiocytosis ,Fraction of inspired oxygen ,Extracorporeal membrane oxygenation ,Medicine ,Humans ,Abnormalities, Multiple ,Fever of unknown origin ,Hemophagocytic lymphohistiocytosis ,business.industry ,Biopsy, Needle ,Infant ,respiratory system ,medicine.disease ,Combined Modality Therapy ,Immunohistochemistry ,Respiration, Artificial ,female genital diseases and pregnancy complications ,Treatment Outcome ,030228 respiratory system ,Macrophage activation syndrome ,Pediatrics, Perinatology and Child Health ,Female ,Radiography, Thoracic ,business ,Pulmonary alveolar proteinosis ,Respiratory Insufficiency ,Tomography, X-Ray Computed ,Follow-Up Studies - Abstract
Pulmonary alveolar proteinosis (PAP) is a rare diffuse lung disease in the pediatric population. There are currently few cases documenting hemophagocytic lymphohistiocytosis as a cause for secondary PAP. We describe an ex-preterm child with secondary hemophagocytic lymphohistiocytosis, complicated by PAP and hypoxemic respiratory failure.
- Published
- 2016